CYCLONESEQ
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

CYCLONESEQ Trademark

Serial Number: 79398858 • Registration: 8122374

CYCLONESEQ is a trademark filed by BGI Hangzhou CycloneSEQ Technology Co., Ltd. on March 18, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

BGI Hangzhou CycloneSEQ Technology Co., Ltd.

Room 301, 3rd Floor, No. 1 Building,

Entity Type: 98

BGI SHENZHEN (3 trademarks)

Main Building, Beishan Industrial Zone,

Entity Type: 99

Trademark Details

Filing Date

March 18, 2024

Registration Date

February 3, 2026

Published for Opposition

December 16, 2025

Goods & Services

Computer software, recorded for managing laboratory information, data, instruments and workflows in the field of genome sequencing; downloadable and recorded computer software for database management; laboratory devices for detecting genetic sequences; laboratory equipment, namely, protein sequence analysis apparatus; nucleic acid sequencers used for analyzing nucleic acids in scientific research; laboratory apparatus and instruments, namely, gene analyzers for detecting genetic sequences.

Apparatus for use in medical analysis, namely, computerized medical recording and analysis apparatus for the diagnosis and analysis of cancer, genetic diseases and microbial infectious diseases; apparatus for blood analysis; medical apparatus and instruments, namely, apparatus for detecting tumors, cancer and genetic diseases; medical apparatus and instruments, namely, apparatus for detecting and treating tumors and cancer; medical apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer and cytology; genetic testing apparatus for medical purposes.

Biological preparations for medical purposes for the treatment of cancer and genetic diseases; medical diagnostic reagents for the analysis of the immune system; preparations for detecting genetic predispositions for medical purposes; reagents for use in medical genetic testing; reagent paper for medical purposes; diagnostic preparations for medical purposes; chemical preparations for medical purposes for the treatment of cancer and genetic diseases; enzyme preparations for medical purposes; preparations for detecting mutation in prion genes for medical purposes; diagnostic biomarker reagents for medical purposes.

Chemical reagents, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical preparations for scientific purposes; biological preparations, other than for medical or veterinary purposes being biological preparations for use in industry and science; test paper, chemical; biological preparations for use in cell cultures, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; diagnostic reagents and preparations, except for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes.

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 3, 2026 FICR
CHANGE OF OWNER RECEIVED FROM IB
Apr 2, 2026 CHLD
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 3, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 3, 2026 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 18, 2025 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 10, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 3, 2025 OPNR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 31, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 1, 2025 GNFN
FINAL REFUSAL E-MAILED
May 1, 2025 GNFR
FINAL REFUSAL WRITTEN
May 1, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 12, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 12, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 12, 2025 COAR
REFUSAL PROCESSED BY IB
Oct 19, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 27, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 26, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 25, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 9, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 4, 2024 REPR